Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation

Feasibility and safety of electrochemotherapy (ECT) in the pancreas: a pre-clinical investigation

Background. Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease generally refractory to standard chemotherapeutic agents; therefore improvements in anticancer therapies are mandatory. A major determinant of therapeutic resistance in PDAC is the poor drug delivery to neoplastic cells, mainly...

Full description

Bibliographic Details
Main Authors: Girelli Roberto, Prejanò Simona, Cataldo Ivana, Corbo Vincenzo, Martini Lucia, Scarpa Aldo, Claudio Bassi
Format: Article
Language:English
Published: Sciendo 2015-06-01
Series:Radiology and Oncology
Subjects:
electroporation
bleomycin
cisplatin
electrochemotherapy
preclinical study
safety
pancreatic adenocarcinoma
Online Access:https://doi.org/10.1515/raon-2015-0013

Internet

https://doi.org/10.1515/raon-2015-0013

Similar Items